Attenuation of biofilm and quorum sensing regulated virulence factors of an opportunistic pathogen Pseudomonas aeruginosa by phytofabricated silver nanoparticles
Microbial Pathogenesis · 2023
DOI: 10.1016/j.micpath.2023.106433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2023. Verfasst von Muzamil Ahmad Rather und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biotechnology, Tezpur University, Napaam, India. Hauptthemen laut MEDLINE: Quorum Sensing, Metal Nanoparticles. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Biotechnology, Tezpur University, Napaam, India.
- Department of Molecular Biology and Biotechnology, Tezpur University, Napaam, India. Electronic address: mandal@tezu.ernet.in.
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Rather, M. A., & Mandal, M. (2023). Attenuation of biofilm and quorum sensing regulated virulence factors of an opportunistic pathogen Pseudomonas aeruginosa by phytofabricated silver nanoparticles. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2023.106433
Vancouver
Rather MA, Mandal M. Attenuation of biofilm and quorum sensing regulated virulence factors of an opportunistic pathogen Pseudomonas aeruginosa by phytofabricated silver nanoparticles. Microbial Pathogenesis. 2023. doi:10.1016/j.micpath.2023.106433
BibTeX
@article{Rather2023,
author = {Rather, Muzamil Ahmad and Mandal, Manabendra},
title = {Attenuation of biofilm and quorum sensing regulated virulence factors of an opportunistic pathogen Pseudomonas aeruginosa by phytofabricated silver nanoparticles},
journal = {Microbial Pathogenesis},
year = {2023},
doi = {10.1016/j.micpath.2023.106433}
}
EUVIMED